LLY β€” Eli Lilly & Company COM lly equity

Ownership history in ORBIMED CAPITAL LLC  Β·  1 quarter on record

This page tracks every 13F SEC filing in which ORBIMED CAPITAL LLC reported a position in Eli Lilly & Company COM lly equity (LLY). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β€” sourced directly from SEC EDGAR 13F filings.

πŸ” Peak position
7.13% (2002 Q4)
πŸ“Š Avg. % of fund
7.13%
πŸ“… First filed
2002 Q4
πŸ“… Last filed
2002 Q4
⏱ Quarters held
1
% of Fund (quarterly)    LLY price (monthly, adj. close)
πŸ“‹ Quarterly Holdings History 1 quarter  β–Ύ
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2002 Q4 INITIATED 230,000 β€” β€” 7.13% $14.6M $33.05

🏒 Other funds also holding LLY

As of 2025 Q4 β€” sorted by position size

LILLY ENDOWMENT INC 3Y 7Y 100.0% Private Capital Advisors, Inc. 3Y 7Y 46.91% XR Securities LLC 3Y 7Y 41.84% Bedel Financial Consulting, Inc. 3Y 7Y 37.93% PNC FINANCIAL SERVICES GROUP, INC. 3Y 7Y 30.13% Goelzer Investment Management, Inc. 3Y 7Y 27.06% Holistic Financial Partners 3Y 7Y 26.45% Cascade Financial Partners, LLC 25.78% SAPIENT CAPITAL LLC 22.72% WEATHERLY ASSET MANAGEMENT L. P. 3Y 7Y 22.67%
← Back to ORBIMED CAPITAL LLC Holdings